$2.26 Billion is the total value of Third Security, LLC's 23 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 20.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XON | Buy | INTREXON CORP | $1,641,528,000 | +10.9% | 62,439,273 | +0.4% | 72.78% | +3.3% |
HALO | HALOZYME THERAPEUTICS INC | $251,547,000 | -15.2% | 19,791,286 | 0.0% | 11.15% | -21.0% | |
ZIOP | ZIOPHARM ONCOLOGY INC | $81,596,000 | +5.5% | 17,815,708 | 0.0% | 3.62% | -1.7% | |
FCSC | Buy | FIBROCELL SCIENCE INC | $79,728,000 | +38.1% | 15,244,427 | +7.2% | 3.54% | +28.6% |
SYN | SYNTHETIC BIOLOGICS INC | $31,613,000 | +68.0% | 12,300,768 | 0.0% | 1.40% | +56.5% | |
EPD | ENTERPRISE PRODS PARTNERS L | $31,040,000 | +4.6% | 447,517 | 0.0% | 1.38% | -2.6% | |
OGEN | ORAGENICS INC | $28,239,000 | +2.1% | 9,839,221 | 0.0% | 1.25% | -4.9% | |
4945SC | KINDER MORGAN ENERGY PARTNERut ltd partner | $23,523,000 | -8.3% | 318,098 | 0.0% | 1.04% | -14.6% | |
PAA | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $22,048,000 | +6.5% | 400,000 | 0.0% | 0.98% | -0.8% | |
ET | Buy | ENERGY TRANSFER EQUITY L P | $17,587,000 | +14.4% | 376,200 | +100.0% | 0.78% | +6.6% |
GEL | GENESIS ENERGY L Punit ltd partn | $11,761,000 | +3.1% | 217,000 | 0.0% | 0.52% | -4.1% | |
CMLP | CRESTWOOD MIDSTREAM PARTNERSunit ltd partner | $6,415,000 | -9.4% | 284,620 | 0.0% | 0.28% | -15.7% | |
NS | NUSTAR ENERGY LP | $6,402,000 | +7.8% | 116,500 | 0.0% | 0.28% | +0.4% | |
MMLP | MARTIN MIDSTREAM PRTNRS L Punit l p int | $6,104,000 | +0.6% | 141,800 | 0.0% | 0.27% | -6.2% | |
TCP | TC PIPELINES LP | $4,649,000 | -1.0% | 97,000 | 0.0% | 0.21% | -8.0% | |
RGP | New | REGENCY ENERGY PARTNERS L P | $4,512,000 | – | 165,750 | +100.0% | 0.20% | – |
CDXS | CODEXIS INC | $3,682,000 | +45.7% | 1,805,000 | 0.0% | 0.16% | +35.8% | |
OVAS | Buy | OVASCIENCE INC | $3,337,000 | +33.6% | 373,224 | +36.6% | 0.15% | +24.4% |
DSCI | Exit | DERMA SCIENCES INC | $0 | – | -78,745 | -100.0% | -0.04% | – |
PVR | Exit | PVR PARTNERS L P | $0 | – | -162,500 | -100.0% | -0.21% | – |
BWP | Exit | BOARDWALK PIPELINE PARTNERSut ltd partner | $0 | – | -195,000 | -100.0% | -0.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-04-25
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HALOZYME THERAPEUTICS INC | 36 | Q1 2022 | 37.6% |
TC PIPELINES LP | 30 | Q3 2020 | 1.1% |
ENTERPRISE PRODS PARTNERS L | 29 | Q2 2020 | 6.7% |
ENERGY TRANSFER LP | 29 | Q2 2020 | 2.7% |
NUSTAR ENERGY LP | 29 | Q2 2020 | 1.3% |
INTREXON CORP | 26 | Q4 2019 | 82.5% |
ZIOPHARM ONCOLOGY INC | 25 | Q2 2020 | 7.5% |
AQUABOUNTY TECHNOLOGIES INC | 23 | Q3 2022 | 16.9% |
SYNTHETIC BIOLOGICS INC | 21 | Q2 2018 | 4.0% |
ORAGENICS INC | 19 | Q4 2017 | 3.9% |
View Third Security, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2022-11-14 |
13F-HR | 2022-11-10 |
13F-HR | 2022-07-28 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-10 |
13F-HR | 2021-08-12 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-16 |
View Third Security, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.